Syringometaplasia

Last updated on: 05.05.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Histological term describing a mature metaplasia of the eccrine ducts. Eccrine squamous syringometaplasia is not a rare histological finding and may be associated with chemotherapy or a variety of non-specific diseases such as infections, neoplastic diseases and inflammatory skin diseases (e.g. scleromyxedema). The changes are mainly observed in the context of chemotherapy.

Various subtypes of syringometaplasia have been described:

  • the squamous type
  • the mucinous type
  • the adenomatous type

LiteratureThis section has been translated automatically.

  1. Bittar PG et al. (2018) Chemotherapy-induced eccrine squamous syringometaplasia in an infant. Pediatr Dermatol 35:e84-e85.
  2. Matei MC et al. (2022) Eccrine squamous syringometaplasia associated with Natalizumab. Dermatol Ther 35:e15576.
  3. Velik C et al. (2022) Sorafenib-induced eccrine squamous syringometaplasia. Australas J Dermatol 63:e189-e190

Last updated on: 05.05.2025